Liposome Formulation Development & Optimization Services

The ultimate frontier in modern medicine is targeted drug delivery, aiming to elevate the therapeutic index by maximizing drug concentration at the diseased site while sparing healthy tissues. Liposomes are a crucial enabler of this mission, offering a versatile platform for protective encapsulation and controlled release. However, developing a truly optimal system—one that achieves superior stability, high encapsulation efficiency (EE), and precise guidance—demands specialized scientific expertise. Creative Biolabs specializes in this intersection of science and precision, leveraging decades of experience to transform complex payload candidates into robust, highly effective delivery systems optimized for your specific research application.

Request a Free Scientific Consultation

Background

The Challenge: Navigating Biological Barriers

Developing a stable liposomal formulation is only the first step. The primary hurdle in achieving therapeutic success is overcoming intrinsic biological barriers:

What Are Liposome?

Liposomes are microscopic vesicles composed of one or more concentric lipid bilayers enclosing an aqueous core. This amphiphilic structure allows them to encapsulate both hydrophilic (in the core) and lipophilic (within the bilayer) therapeutic agents, ranging from small molecules to complex nucleic acids. Their high biocompatibility, low immunogenicity, and structural versatility make them the most clinically successful class of nanocarriers, essential for reducing systemic toxicity and enhancing drug efficacy.

The performance of a liposomal system—specifically its ability to retain the drug and control its release—is directly governed by its lipid composition.

Rational Liposome Formulation Development

This crucial starting phase establishes the fundamental stability and architecture of liposome, tailored to the cargo's unique properties. Key considerations include:

• Payload Compatibility Screening: Determining the optimal lipid-to-drug ratio based on the cargo's pKa, hydrophobicity, and molecular size to maximize initial loading.
• Smart Lipid Selection: Precise selection of phospholipids, charge-modulating lipids, and cholesterol concentration to control membrane rigidity and stability.
• Loading Strategy Design: Developing high-yield Active Loading protocols (e.g., pH gradient, sulfate gradient) for small molecules or passive encapsulation methods for large biologics.

Data-Driven Formulation Optimization

Optimization is a rigorous, iterative process applying Quality by Design (QbD) principles to refine the product for predictable in vivo performance:

• Narrow PDI Guarantee: Fine-tuning critical process parameters (CPPs) to achieve a sub-0.3 Polydispersity Index—essential for reproducible biodistribution and successful targeting.
• Zeta Potential Engineering: Precisely adjusting surface charge (Zeta Potential) to enhance colloidal stability, minimize aggregation, and tune cell/membrane interactions.
• Enhanced Stability Profiling: Incorporating stabilizers (e.g., antioxidants, cryoprotectants) and optimizing lyophilization cycles to ensure long-term, verifiable shelf-life.

Creative Biolabs offers customized liposome formulations tailored to your specific payload and target. Furthermore, to facilitate rapid research, we maintain a selection of off-the-shelf liposome products and kits in stock, which can help customers quickly select suitable components for immediate use.

Conventional Liposomes Functionalized Liposomes Advanced Liposomes Structural Liposomes

Conventional Liposome Development

We develop standard, high-quality systems optimized for fundamental parameters:

Drug-Loaded Liposomes

Optimization for maximum EE of small molecule drugs using passive or active loading methods.

Long-Circulating Liposomes

Utilizing PEGylation and other surface modifications to minimize MPS uptake and maximize plasma half-life.

Charged Liposomes

Controlling surface charge (neutral, cationic, anionic) to modulate stability, interaction with biological membranes, and transfection efficiency.

Fluorescent Liposomes

Incorporation of fluorescent tags or probes for in vitro and in vivo imaging and tracking studies.

Functionalized Liposome Development

Achieve specific, active targeting by integrating Targeted Modules into the nanocarrier (liposome) shell:

Antibody-Conjugated Liposomes (Immunoliposomes)

Conjugation of antibodies to the liposome surface for targeted binding to specific cell surface antigens.

Peptide-Conjugated Liposomes

Utilizing short, highly specific peptides as targeting ligands to enhance tissue or receptor specificity.

Aptamer-Conjugated Liposomes

Integration of synthetic oligonucleotide aptamers for superior binding affinity and selectivity against target cells.

Protein-Conjugated Liposomes

Conjugation of targeting proteins to the liposome surface for enhanced receptor recognition and cellular uptake.

Carbohydrate-Conjugated Liposomes

Attachment of specific carbohydrates to the liposome surface for lectin-mediated targeting and selective binding.

Small Molecule-Conjugated Liposomes

Utilizing small compounds as targeting ligands to achieve precise accumulation with minimal immunogenicity.

Advanced Liposome Development

For complex or refractory disease targets, we offer cutting-edge, bio-inspired architectures:

Stimuli-Responsive Liposomes

Designing systems that undergo triggered release in response to localized tumor microenvironment cues (e.g., pH, temperature, or enzyme concentration).

Cell Membrane-Coated Liposomes

Encapsulating liposomes with membranes derived from natural cells (e.g., red blood cells, cancer cells) to leverage innate homing or immune-evasive properties.

Exosome-Hybrid Liposomes

Carriers created by fusing or hybridizing synthetic liposomes with natural exosomes, leveraging the inherent surface proteins and biological targeting capabilities of the natural exosome.

Exosome-Mimicked Liposomes

Synthetic liposomes engineered with lipid compositions and surface properties that closely resemble natural exosomes, promoting enhanced biocompatibility.

Structural Liposome Development

We optimize liposome structure and size distribution for defined applications, including:

• Small Unilamellar Vesicles (SUV): Typically <100 nm, offering high surface area and long circulation potential.
• Large Unilamellar Vesicles (LUV): Ranging from 100 nm to 1 μm suitable for passive targeting (EPR) and larger payloads.
• Giant Unilamellar Vesicles (GUV): Ideal for model membrane studies and cell interaction research (>1 μm).
• Multilamellar Large Vesicles (MLV) & Multivesicular Liposomes (MVL): Used for sustained release applications, often via non-systemic routes.

Fig. 1 Types of liposomes based on structure and size.¹

Workflow

Applications of Targeted Liposomes in Modern Research

Creative Biolabs' liposome services empower researchers to tackle complex delivery challenges across high-impact therapeutic fields.

• Oncology: Engineering Immunoliposomes and Stimuli-Responsive systems to achieve active targeting and enhanced accumulation within solid tumors (EPR effect), dramatically improving the safety profile of chemotherapy and radiopharmaceuticals.
• Nucleic Acid Therapeutics: Designing highly stable LNPs and liposomes essential for the successful delivery of fragile mRNA (vaccines/protein replacement), siRNA, and CRISPR-Cas9 components to the cytosol, enabling genetic therapies.
• Neurotherapeutics: Developing specialized, surface-modified liposomes capable of crossing the Blood-Brain Barrier (BBB), unlocking treatments for Alzheimer's, Parkinson's, and other CNS disorders.
• Advanced Drug Modalities: Providing reliable delivery for novel, highly potent agents such as protein degraders, ensuring stability and efficient intracellular uptake for functional effect.
• Vaccinology: Formulating liposomal adjuvants and delivery systems that enhance immune response by optimizing antigen presentation and stability.

Creative Biolabs empowers researchers by providing the tools and expertise to achieve targeted delivery, ensuring your pioneering science reaches its full therapeutic potential. Contact our dedicated scientific team today to discuss your specific liposome challenge.

Related Services

LNP Development Services

Bioconjugation Services

Targeted Module Synthesis Services

Lipid Synthesis for Liposomes Development

Analytical & Characterization Service

FAQs

Reference

1. Amarandi, Roxana-Maria, et al. "Liposomal-based formulations: A path from basic research to temozolomide delivery inside glioblastoma tissue." Pharmaceutics 14.2 (2022): 308. https://doi.org/10.3390/pharmaceutics14020308. Distributed under Open Access license CC BY 4.0, without modification.